𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon

✍ Scribed by G. A. Petroianu; K. Arafat; S. M. Nurulain; K. Kuča; J. Kassa

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
623 KB
Volume
27
Category
Article
ISSN
0260-437X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro oxime protection of human red b
In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate
✍ D. E. Lorke; M. Y. Hasan; K. Arafat; K. Kuča; K. Musilek; A. Schmitt; G. A. Petr 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB

Oximes are enzyme reactivators used in treating poisoning with organophosphorus cholinesterase (AChE) inhibitors. The oxime dose which can be safely administered is limited by the intrinsic toxicity of the substances such as their own AChE-inhibiting tendency. Clinical experience with the available

In vitro protection of red blood cell ac
In vitro protection of red blood cell acetylcholinesterase by metoclopramide from inhibition by organophosphates (paraoxon and mipafox)
✍ Georg Petroianu; Kholoud Arafat; Melita Kosanovic; Ayman Saleh; Vijayasarathy Ca 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

Metoclopramide (MCP) is a dopamine receptor antagonist and serotonin receptor agonist widely used as an antiemetic and gastric prokinetic drug. In addition, MCP is a reversible inhibitor of cholinesterases from the human central nervous system and blood, and may have a red blood cell (RBC) acetylcho

Five oximes (K-27, K-33, K-48, BI-6 and
Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibitied by paraoxon
✍ G. A. Petroianu; K. Arafat; K. Kuča; J. Kassa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

Oximes are cholinesterase reactivators of use in poisoning with organophosphorus compounds. Pralidoxime (PRX) is used clinically as an adjunct to atropine in such exposure. Clinical experience with PRX (and other oximes) is, however, disappointing and routine use has been questioned. In addition it

Pralidoxime and l -lactate effects in vi
Pralidoxime and l -lactate effects in vitro on the inhibition of acetylcholinesterase by paraoxon: pralidoxime does not confer superior protection
✍ Georg Petroianu; Christina Roth; Ulrike Beha; Joseph Fisher; Wolfgang Bergler; R 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

## Abstract Intoxication with the organophosphorus compound paraoxon (POX), an inhibitor of serine hydrolases, is frequent. Although oximes are the only enzyme reactivators presently available, clinical experience with their use was rather disappointing. Recent work has shown that under certain con

Comparison of in vitro potency of oximes
Comparison of in vitro potency of oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited acetylcholinesterase in various parts of pig brain
✍ Kamil Kuca; Jiri Cabal; Jiri Kassa; Daniel Jun; Martina Hrabinová 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

The potency of currently used oximes to reactivate sarin-inhibited acetylcholinesterase (AChE) in various parts of pig brain and whole pig brain was evaluated using in vitro methods. Significant differences in reactivation potency among all tested oximes were observed. At concentrations (10 - ----4

Clustering of erythrocytes by fibrinogen
Clustering of erythrocytes by fibrinogen is inhibited by carnitine: Evidence that sulfhydryl groups on red blood cell membranes are involved in carnitine actions
✍ Irving B. Fritz; Katherine Wong; Krystyna Burdzy 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 961 KB

Carnitine is bound by intact red blood cells, by red blood cell ghosts, and by glutaraldehyde-fixed human erythrocytes in a non-saturable, temperaturedependent manner. Binding of carnitine by these preparations is blocked by sulfhydryl reagents. Incubation or preincubation of red blood cell preparat